It's interesting 150mg group was doing numerically better than 300mg group in reduction in both annual relapse rate and risk of sustained disability progression while 300mg group did do better numerically in secondary endpoint than 150mg group.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.